U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C38H41N3O2
Molecular Weight 571.751
Optical Activity UNSPECIFIED
Defined Stereocenters 0 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BIPICANA

SMILES

CCCCCN1C=C(C2C=CC=CC12)C(=O)N(C(=O)C3=CN(CCCCC)C4=C3C=CC=C4)C5=C6C=CC=CC6=CC=C5

InChI

InChIKey=JUJSXRUYGOTLSI-UHFFFAOYSA-N
InChI=1S/C38H41N3O2/c1-3-5-13-24-39-26-32(30-19-9-11-21-34(30)39)37(42)41(36-23-15-17-28-16-7-8-18-29(28)36)38(43)33-27-40(25-14-6-4-2)35-22-12-10-20-31(33)35/h7-12,15-23,26-27,30,34H,3-6,13-14,24-25H2,1-2H3

HIDE SMILES / InChI

Molecular Formula C38H41N3O2
Molecular Weight 571.751
Charge 0
Count
Stereochemistry MIXED
Additional Stereochemistry No
Defined Stereocenters 0 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Tue Apr 01 17:00:40 GMT 2025
Edited
by admin
on Tue Apr 01 17:00:40 GMT 2025
Record UNII
PR85BBU47K
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
N, N-BIS(1-PENTYLINDOL-3-YL-CARBOXY)NAPHTYLAMINE
Preferred Name English
BIPICANA
Common Name English
N-(1-NAPHTHYL)-1-PENTYL-N-(1-PENTYL-3A,7A-DIHYDROINDOLE-3-CARBONYL)INDOLE-3-CARBOXAMIDE
Systematic Name English
Classification Tree Code System Code
WIKIPEDIA Designer-drugs-BiPICANA
Created by admin on Tue Apr 01 17:00:40 GMT 2025 , Edited by admin on Tue Apr 01 17:00:40 GMT 2025
Code System Code Type Description
FDA UNII
PR85BBU47K
Created by admin on Tue Apr 01 17:00:40 GMT 2025 , Edited by admin on Tue Apr 01 17:00:40 GMT 2025
PRIMARY
MANUFACTURER PRODUCT INFORMATION
BIPICANA
Created by admin on Tue Apr 01 17:00:40 GMT 2025 , Edited by admin on Tue Apr 01 17:00:40 GMT 2025
PRIMARY (BiPICANA, compound 2). Compound 2 was purified by silica and octadecyl group bonded type silica gel (C18, ODS) columns and confirmed by liquid chromatographymass spectrometry, accurate mass spectrometry, nuclear magnetic resonance spectroscopy, and X-ray crystallography. No pharmacological information on compound 2 has been reported previouslyour experiments on the binding ability of compound 2 to cannabinoid receptors revealed that it has affinities for CB1 and CB2 receptors (EC50 = 3.80 and 8.77 107 M, respectively). This is the first report identifying compound 2 in a dubious herbal product and demonstrating its binding affinities to cannabinoid receptors.
PUBCHEM
162368425
Created by admin on Tue Apr 01 17:00:40 GMT 2025 , Edited by admin on Tue Apr 01 17:00:40 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> AGONIST
TARGET -> AGONIST
Related Record Type Details
ACTIVE MOIETY